Dr. Safdi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
136 Country Club Drive
Telluride, CO 81435
Summary
- Dr. Alan Safdi is the Chief Medical Officer Quadrant Health which is Co-owned by Stanford University and Mayo Clinic. He also serves as CEO of MD Health and medical director of the Telluride Longevity Institute and Vet. Endo. Institute. He co-founded eMerge Health Solutions, Ohio GI and Liver Institute, Consultants for Clinical Research, Pathology and Anesthesia outpatient programs, and multiple outpatient endoscopy centers. As President of the Consultants for Clinical Research he was involved in numerous research projects and has authored or co-authored many publications. He was elected President of the Ohio GI Society and was Chairman of Ohio GI and the Dept of Gastroenterology at Deaconess Hospital. He is an internist and gastroenterologist in Ohio and Colorado. He received his medical degree from University of Cincinnati College of Medicine and residency at the Univ. Of California. He is experienced in inflammatory bowel disease, colorectal cancer screening, clinical research, colon cancer, and ulcerative colitis and crohn's disease. He not only lectures on GI topics but lectures on health, wellness and longevity. He also has a wellness evidence based newsletter and Apple podcasts on these topics.
Education & Training
- University of Cincinnati Medical Center/College of MedicineFellowship, Gastroenterology, 1981 - 1983
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 1978 - 1981
- University of Cincinnati College of MedicineClass of 1978
- Northwestern UniversityBA, Biology, Phi Beta Kappa, Graduated in 3 years, 1971 - 1974
Certifications & Licensure
- OH State Medical License 1981 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Top Doctor Award Cincinnati Magazine, 1990-2016
- AOA University of Cincinnati, 1978
- Phi Beta Kappa 1974
- Join now to see all
Clinical Trials
- Efficacy and Tolerability Study of Natura-Alpha in the Treatment of Patients With Active Ulcerative Colitis Start of enrollment: 2010 Jul 01
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease Start of enrollment: 2013 Sep 01
Publications & Presentations
PubMed
- 12 citationsReview Article: Increasing the Dose of Oral Mesalazine Therapy for Active Ulcerative Colitis Does Not Improve Remission RatesA. V. Safdi, Russell D. Cohen
Alimentary Pharmacology & Therapeutics. 2007-11-01 - 18 citationsMisoprostol in the treatment of duodenal ulcer refractory to H2-blocker therapy: A placebo-controlled, multicenter, double-blind, randomized trialRichard D. Newman, Norman Gitlin, Enrique J. Lacayo, Alan V. Safdi, Edward J. Ramsey
The American Journal of Medicine. 1987-07-27 - 27 citationsResidue-free sodium phosphate tablets (OsmoPrep) versus Visicol for colon cleansing: a randomized, investigator-blinded trialLawrence Wruble, Michael P. DeMicco, Jeffrey Medoff, Alan Safdi, Jeffrey Bernstein
Gastrointestinal Endoscopy. 2007-04-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: